CYC 1.19% $1.70 cyclopharm limited

From the Chairmans address at AGM 4th May:'The USFDA has advised...

  1. 1,771 Posts.
    lightbulb Created with Sketch. 243
    From the Chairmans address at AGM 4th May:

    'The USFDA has advised of its goal date to complete its full review of the NDA late next month, after which time, we expect to secure approval and begin US sales as soon as is practicable.'

    So end June early July for approval
 
watchlist Created with Sketch. Add CYC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.